SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-21-011664
Filing Date
2021-04-05
Accepted
2021-04-05 17:28:15
Documents
2
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A brhc10022785_sc13ga.htm SC 13G/A 79556
2 JOINT FILING AGREEMENT brhc10022785_ex99-1.htm EX-99.1 6739
  Complete submission text file 0001140361-21-011664.txt   88070
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90656 | Film No.: 21806786
SIC: 2836 Biological Products, (No Diagnostic Substances)